-+ 0.00%
-+ 0.00%
-+ 0.00%

Ceribell forecasts FY 2026 revenue of $114 million-$117 million

PUBT·08/10/2026 21:09:46
Listen to the news
Ceribell forecasts FY 2026 revenue of $114 million-$117 million
  • Ceribell issued FY 2026 revenue guidance of $114 million-$117 million on Aug. 10, 2026.
  • Q2 2026 revenue rose 33% year over year; YTD 2026 gross margin was 90% as of June 30, 2026.
  • Management pegged the U.S.-only market opportunity at $3.5 billion, including an adult seizure acute care market of more than $2 billion.
  • Pediatric and neonate indication expansion added an estimated $400 million opportunity; commercial launch began in Q1 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.